CAREERS |E-NEWS SIGN UP | CONTACT US | HOME     


< Back to News

Neurodyn Cognition Inc. Appoints new Director and Executive Chairman
Friday, December 8, 2017

Neurodyn Cognition Inc. (NCI)has announced the appointment of Anthony Giovinazzo as a director and Executive Chairman of the Company.  NCI is focused on the development of Memogain, a prodrug of an approved Alzheimer’s therapy with significantly improved safety and efficacy. Giovinazzo has
over 25 years of experience in the biotech industry and has been the recipient of a number of industry honours and awards.
















 





 





 





 





 





 





 







View PDF